Home › Funds › PSP Research LLC › DYN

PSP Research LLC position in DYN

DYNE THERAPEUTICS INC · Health Care

PSP Research LLC reported holding 10,000 shares of DYN (DYNE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$161K, representing 0.11% of its reported portfolio and ranking #39 among its reported holdings. PSP Research LLC has disclosed DYN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)10.00K sh
Reported value held$161.10K
Portfolio Weight0.11%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's DYN position evolved

PSP Research LLC first disclosed a stake in DYN in Q4 2025 at 21,535 shares (US$421K). The position peaked in Q2 2026 at 20,000 shares, worth US$444K. Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 10,000 shares valued at US$161K — a reduction of -10,000 shares quarter over quarter.. Notable position changes include a 50% trim in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 21.54K $421.23K New
Q1 2026 20.00K $362.60K Reduce
Q2 2026 20.00K $444.20K Hold
Q3 2026 10.00K $161.10K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DYN and 13F data

DYN (DYNE THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in DYN — the largest reported positions include Atlas Venture Life Science Advisors, LLC (US$151.0M), TCG Crossover Management, LLC (US$102.5M), FCPM III SERVICES B.V. (US$85.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DYN

All DYN fund holders →

FAQ

How long has PSP Research LLC held DYN?

PSP Research LLC has disclosed DYN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in DYN?

As of Q3 2026, PSP Research LLC holds 10.00K shares of DYN (DYNE THERAPEUTICS INC), valued at $161.10K, representing 0.11% of its reported portfolio and ranking #39.

Has PSP Research LLC been buying or selling DYN?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in DYN. The position peaked in Q2 2026 at 20.00K shares.

Which other funds hold DYN?

Other major institutional holders of DYN include Atlas Venture Life Science Advisors, LLC, TCG Crossover Management, LLC, FCPM III SERVICES B.V., among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.